Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 2161 AL 2175

How Mobile Health Technology and Electronic Health Records Will Change Care of Patients with Parkinson's Disease

Hansen C, Sanchez-Ferro A, Maetzler W.

J Parkinsons Dis. 2018;8(s1):S41-S45. doi: 10.3233/JPD-181498.

MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson's Disease

Klein C, Hattori N, Marras C.

J Parkinsons Dis. 2018;8(s1):S25-S30. doi: 10.3233/JPD-181505.

Management of Parkinson's Disease 20 Years from Now: Towards Digital Health Pathways

Klucken J, Krüger R, Schmidt P, Bloem BR.

J Parkinsons Dis. 2018;8(s1):S85-S94. doi: 10.3233/JPD-181519.

[Backward walking and its application in geriatric patients.]

Klemenov AV.

Adv Gerontol. 2018;31(3):428-432.

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus

Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM.

CNS Spectr. 2018 Dec;23(6):402-413. doi: 10.1017/S1092852918001359.

Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review

Zhang P, Li Y, Nie K, Wang L, Zhang Y.

BMC Neurol. 2018 Dec 27;18(1):221. doi: 10.1186/s12883-018-1230-1.

Natural Compounds for the Management of Parkinson's Disease and Attention-Deficit/Hyperactivity Disorder

Corona JC.

Biomed Res Int. 2018 Nov 22;2018:4067597. doi: 10.1155/2018/4067597. eCollection 2018.

New Developments on the Adenosine Mechanisms of the Central Effects of Caffeine and Their Implications for Neuropsychiatric Disorders

Ferré S, Díaz-Ríos M, Salamone JD, Prediger RD.

J Caffeine Adenosine Res. 2018 Dec 1;8(4):121-131. doi: 10.1089/caff.2018.0017. Epub 2018 Dec 7.

Pathogenic Feed-Forward Mechanisms in Alzheimer's and Parkinson's Disease Converge on GSK-3

Albeely AM, Ryan SD, Perreault ML.

Brain Plast. 2018 Dec 26;4(2):151-167. doi: 10.3233/BPL-180078.

[The treatment of advanced Parkinson's disease]

Klivényi P , Vécsei L .

Ideggyogy Sz. 2018 Nov 30;71(11-12):377-383. doi: 10.18071/isz.71.0377.

REM sleep behaviour disorder (RBD): risk for Parkinsonism and executive dysfunction in elderly

Lerche S, Brockmann K.

Oncotarget. 2018 Dec 4;9(95):36732-36733. doi: 10.18632/oncotarget.26417. eCollection 2018 Dec 4.

The Utility of Zebrafish as a Model for Screening Developmental Neurotoxicity

d'Amora M, Giordani S.

Front Neurosci. 2018 Dec 18;12:976. doi: 10.3389/fnins.2018.00976. eCollection 2018.

The Involvement of Iron in Traumatic Brain Injury and Neurodegenerative Disease

Daglas M, Adlard PA.

Front Neurosci. 2018 Dec 20;12:981. doi: 10.3389/fnins.2018.00981. eCollection 2018.

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response

Bachiller S, Jiménez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T, Boza-Serrano A.

Front Cell Neurosci. 2018 Dec 18;12:488. doi: 10.3389/fncel.2018.00488. eCollection 2018.

Advances in Parkinson's Disease: 200 Years Later

Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernández-Santiago R, Monje MHG, Trigo-Damas I, Blanco-Prieto MJ, Blesa J.

Front Neuroanat. 2018 Dec 14;12:113. doi: 10.3389/fnana.2018.00113. eCollection 2018.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias